Private Advisory Group’s VanEck Pharmaceutical ETF PPH Stock Holding History

Private Advisory Group’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5,648	Closed	-$487K	–	230
2024 Q4	$487K	Sell	5,648 -72	-1%	-$6.51K	0.05%	149
2024 Q3	$544K	Sell	5,720 -32,274	-85%	-$3.07M	0.06%	143
2024 Q2	$3.48M	Buy	37,994 +128	+0.3%	+$11.4K	0.45%	58
2024 Q1	$3.43M	Sell	37,866 -1,670	-4%	-$146K	0.49%	61
2023 Q4	$3.22M	Buy	39,536 +1,258	+3%	+$98.6K	0.56%	49
2023 Q3	$3.06M	Buy	38,278 +127	+0.3%	+$10.2K	0.6%	45
2023 Q2	$3.01M	Buy	+38,151	New	+$2.99M	0.6%	43

Other funds holding PPH

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return

Private Advisory Group's PPH Position: Q1 2025 in Review

Private Advisory Group sold out of VanEck Pharmaceutical ETF (PPH) in Q1 2025, closing a stake of 5,648 shares — an estimated $487K sold.

Private Advisory Group first reported a position in PPH in Q2 2023 and held it in 7 quarters. The position peaked at $3.48M in Q2 2024. 136 funds tracked by Wall St. Rank hold PPH as of Q1 2025.

Private Advisory Group reported no remaining VanEck Pharmaceutical ETF position as of Q1 2025 after selling out during the quarter.
Private Advisory Group sold 5,648 VanEck Pharmaceutical ETF shares in Q1 2025, an estimated $487K.
Private Advisory Group first reported a position in VanEck Pharmaceutical ETF in Q2 2023 and held it in 7 quarters.
Private Advisory Group's VanEck Pharmaceutical ETF position peaked at $3.48M in Q2 2024.
136 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2025.

Based on Private Advisory Group's 13F filing for Q1 2025, filed 8 May 2025.